Advertisement

Cell Membrane Coated Nanoparticles: An Emerging Biomimetic Nanoplatform for Targeted Bioimaging and Therapy

  • Veena Vijayan
  • Saji Uthaman
  • In-Kyu ParkEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1064)

Abstract

Biomimetic nanoplatform being a recent and emerging strategy plays an important role in a wide variety of applications. The different types of membranes used for coating include membranes from red blood cells, platelets, leucocytes, neutrophils, cancer cells, stem cells, etc. The as obtained membrane vesicles are fused onto the core nanoparticles through extrusion, sonication, electroporation. Biomimetic nanoparticles attain special functions which include ligand recognition and targeting, long blood circulation, immune escaping, tumor targeting depending on the core-shell interactions. The membrane coated nanoparticles indeed mimic the source cells and improves the therapeutic efficacy of drugs other cargos through specific delivery and enhanced accumulation in the tumor.

Keywords

Biomimetic Nanoparticles Ligand targeting Immune escape 

References

  1. Allouche J (2013) Synthesis of organic and bioorganic nanoparticles: an overview of the preparation methods. In: Nanomaterials: a danger or a promise? Springer, London, pp 27–74.  https://doi.org/10.1007/978-1-4471-4213-3 CrossRefGoogle Scholar
  2. Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y (2016) Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 27;10(8):7738–7748.  https://doi.org/10.1021/acsnano.6b03148 CrossRefGoogle Scholar
  3. Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, Su B, Ruan H, Ran D, Fang RH, Zhang L (2017) A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release 264:102.  https://doi.org/10.1016/j.jconrel.2017.08.027 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Chen Z, Zhao P, Luo Z, Zheng M, Tian H, Gong P, Gao G, Pan H, Liu L, Ma A, Cui H (2016) Cancer cell membrane–biomimetic nanoparticles for homologous-targeting dual-modal imaging and Photothermal therapy. ACS Nano 10(11):10049–10057.  https://doi.org/10.1021/acsnano.6b04695 CrossRefPubMedPubMedCentralGoogle Scholar
  5. Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, Ying M, Jiang Y, Kroll AV, Gao W (2017) Erythrocyte–platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater 29(16):1606209.  https://doi.org/10.1002/adma.201606209 CrossRefGoogle Scholar
  6. Ding H, Lv Y, Ni D, Wang J, Tian Z, Wei W, Ma G (2015) Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer. Nanoscale 7(21):9806–9815.  https://doi.org/10.1039/C5NR02470F CrossRefPubMedPubMedCentralGoogle Scholar
  7. Fang RH, Hu CM, Luk BT, Gao W, Copp JA, Tai Y, O’Connor DE, Zhang L (2014) Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14(4):2181–2188.  https://doi.org/10.1021/nl500618u CrossRefPubMedPubMedCentralGoogle Scholar
  8. Fu Q, Lv P, Chen Z, Ni D, Zhang L, Yue H, Yue Z, Wei W, Ma G (2015) Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale 7(9):4020–4030.  https://doi.org/10.1039/C4NR07027E CrossRefPubMedPubMedCentralGoogle Scholar
  9. Gao W, Zhang L (2015) Coating nanoparticles with cell membranes for targeted drug delivery. J Drug Target 23(7–8):619–626.  https://doi.org/10.3109/1061186X.2015.1052074 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gao C, Lin Z, Jurado-Sánchez B, Lin X, Wu Z, He Q (2016) Stem cell membrane coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small 12(30):4056–4062.  https://doi.org/10.1002/smll.201600624 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Gao L, Han L, Ding X, Xu J, Wang J, Zhu J, Lu W, Sun J, Yu L, Yan Z, Wang Y (2017a) An effective intracellular delivery system of monoclonal antibody for treatment of tumors: erythrocyte membrane-coated self-associated antibody nanoparticles. Nanotechnology 28(33):335101.  https://doi.org/10.1088/1361-6528/aa7c43 CrossRefPubMedPubMedCentralGoogle Scholar
  12. Gao M, Liang C, Song X, Chen Q, Jin Q, Wang C, Liu Z (2017b) Erythrocyte membrane enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv Mater 29(35).  https://doi.org/10.1002/adma.201701429 CrossRefGoogle Scholar
  13. He W, Frueh J, Wu Z, He Q (2016a) Leucocyte membrane-coated janus microcapsules for enhanced photothermal cancer treatment. Langmuir 32(15):3637–3644.  https://doi.org/10.1021/acs.langmuir.5b04762 CrossRefPubMedPubMedCentralGoogle Scholar
  14. He W, Frueh J, Wu Z, He Q (2016b) How leucocyte cell membrane modified janus microcapsules are phagocytosed by cancer cells. ACS Appl Mater Interfaces 8(7):4407–4415.  https://doi.org/10.1021/acsami.5b10885 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L (2011) Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci 108(27):10980–10985.  https://doi.org/10.1073/pnas.1106634108 CrossRefPubMedPubMedCentralGoogle Scholar
  16. Hu CM, Fang RH, Copp J, Luk BT, Zhang L (2013) A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol 8(5):336–340.  https://doi.org/10.1038/nnano.2013.54 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z (2015a) Anticancer platelet mimicking nanovehicles. Adv Mater 27(44):7043–7050.  https://doi.org/10.1002/adma.201503323 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, Carpenter C (2015b) Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526(7571):118–121.  https://doi.org/10.1038/nature15373 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Jiang X, Wang K, Zhou Z, Zhang Y, Sha H, Xu Q, Wu J, Wang J, Wu J, Hu Y, Liu B (2017a) Erythrocyte membrane nanoparticles improve the intestinal absorption of paclitaxel. Biochem Biophys Res Commun 488(2):322–328.  https://doi.org/10.1016/j.bbrc.2017.05.042 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Jiang Q, Luo Z, Men Y, Yang P, Peng H, Guo R, Tian Y, Pang Z, Yang W (2017b) Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy. Biomaterials 143:29–45.  https://doi.org/10.1016/j.biomaterials.2017.07.027 CrossRefPubMedPubMedCentralGoogle Scholar
  21. Kang T, Zhu Q, Wei D, Feng J, Yao J, Jiang T, Song Q, Wei X, Chen H, Gao X, Chen J (2017) Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano 11(2):1397–1411.  https://doi.org/10.1021/acsnano.6b06477 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Kroll AV, Fang RH, Zhang L (2016) Biointerfacing and applications of cell membrane-coated nanoparticles. Bioconjug Chem 28(1):23–32.  https://doi.org/10.1021/acs.bioconjchem.6b00569 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, Fu C, Li Y, Qu Q, Zhang Y, Ji S (2011) Silica nanorattle–doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 5(9):7462–7470.  https://doi.org/10.1021/nn202399w CrossRefPubMedPubMedCentralGoogle Scholar
  24. Li J, Ai Y, Wang L, Bu P, Sharkey CC, Wu Q, Wun B, Roy S, Shen X, King MR (2016) Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials 76:52–65.  https://doi.org/10.1016/j.biomaterials.2015.10.046 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Li SY, Cheng H, Qiu WX, Zhang L, Wan SS, Zeng JY, Zhang XZ (2017a) Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials 142:149–161.  https://doi.org/10.1016/j.biomaterials.2017.07.026 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Li SY, Xie BR, Cheng H, Li CX, Zhang MK, Qiu WX, Liu WL, Wang XS, Zhang XZ (2017b) A biomimetic theranostic O2-meter for cancer targeted photodynamic therapy and phosphorescence imaging. Biomaterials 151:1.  https://doi.org/10.1016/j.biomaterials.2017.10.021 CrossRefPubMedPubMedCentralGoogle Scholar
  27. Luk BT, Zhang L (2015) Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release 220:600–607.  https://doi.org/10.1016/j.jconrel.2015.07.019 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Luk BT, Hu CM, Fang RH, Dehaini D, Carpenter C, Gao W, Zhang L (2014) Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6(5):2730–2737.  https://doi.org/10.1039/C3NR06371B CrossRefPubMedPubMedCentralGoogle Scholar
  29. Luk BT, Fang RH, Hu CM, Copp JA, Thamphiwatana S, Dehaini D, Gao W, Zhang K, Li S, Zhang L (2016) Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics 6(7):1004 https://doi.org/10.7150%2Fthno.14471CrossRefPubMedCentralGoogle Scholar
  30. Maher J, Davies ET (2004) Targeting cytotoxic T lymphocytes for cancer immunotherapy. Br J Cancer 91(5):817–821.  https://doi.org/10.1038/sj.bjc.6602022 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV, Isenhart L (2013a) Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles. Nat Nanotechnol 8(1):61 https://doi.org/10.1038%2Fnnano.2012.212CrossRefPubMedCentralGoogle Scholar
  32. Parodi A, Quattrocchi N, Van De Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV, Isenhart L (2013b) Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 8(1):61–68.  https://doi.org/10.1038/nnano.2012.212 CrossRefPubMedPubMedCentralGoogle Scholar
  33. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39–51.  https://doi.org/10.1016/j.cell.2010.03.014 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Rao L, Bu LL, Xu JH, Cai B, Yu GT, Yu X, He Z, Huang Q, Li A, Guo SS, Zhang WF (2015) Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance. Small 11(46):6225–6236.  https://doi.org/10.1002/smll.201502388 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Rao L, Cai B, Bu LL, Liao QQ, Guo SS, Zhao XZ, Dong WF, Liu W (2017a) Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano 11:3496–3505.  https://doi.org/10.1021/acsnano.7b00133 CrossRefPubMedPubMedCentralGoogle Scholar
  36. Rao L, Meng QF, Bu LL, Cai B, Huang Q, Sun ZJ, Zhang WF, Li A, Guo SS, Liu W, Wang TH (2017b) Erythrocyte membrane coated Upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl Mater Interfaces 9(3):2159–2168.  https://doi.org/10.1021/acsami.6b14450 CrossRefPubMedPubMedCentralGoogle Scholar
  37. Rao L, He Z, Meng QF, Zhou Z, Bu LL, Guo SS, Liu W, Zhao XZ (2017c) Effective cancer targeting and imaging using macrophage membrane camouflaged upconversion nanoparticles. J Biomed Mater Res A 105(2):521–530.  https://doi.org/10.1002/jbm.a.35927 CrossRefPubMedPubMedCentralGoogle Scholar
  38. Ren X, Zheng R, Fang X, Wang X, Zhang X, Yang W, Sha X (2016) Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials 92:13–24.  https://doi.org/10.1016/j.biomaterials.2016.03.026 CrossRefPubMedPubMedCentralGoogle Scholar
  39. Ren H, Liu J, Li Y, Wang H, Ge S, Yuan A, Hu Y, Wu J (2017) Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy. Acta Biomater 59:269–282.  https://doi.org/10.1016/j.actbio.2017.06.035 CrossRefPubMedPubMedCentralGoogle Scholar
  40. Subcellular fractionation protocol, Abcam 2016Google Scholar
  41. Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W, Zhang P, Zhang Z, Yu H, Wang S, Li Y (2016) Cancer cell biomimetic nanoparticles for targeted therapy of homotypic tumors. Adv Mater 28(43):9581–9588.  https://doi.org/10.1002/adma.201602173 CrossRefPubMedPubMedCentralGoogle Scholar
  42. Suski JM, Lebiedzinska M, Wojtala A, Duszynski J, Giorgi C, Pinton P, Wieckowski MR (2014) Isolation of plasma membrane associated membranes from rat liver. Nat Protoc 9(2):312–322.  https://doi.org/10.1038/nprot.2014.016 CrossRefPubMedPubMedCentralGoogle Scholar
  43. Tan MC, Chow GM, Ren L, Zhang Q (2009) Inorganic nanoparticles for biomedical applications. InNanoSci Biomed:272–289 Springer, Berlin/Heidelberg.  https://doi.org/10.1007/978-3-540-49661-8_11 CrossRefGoogle Scholar
  44. Tan S, Wu T, Zhang D, Zhang Z (2015) Cell or Cell Membrane-Based Drug Delivery Systems. Theranostics 5(8):863–881CrossRefPubMedCentralGoogle Scholar
  45. Tian H, Luo Z, Liu L, Zheng M, Chen Z, Ma A, Liang R, Han Z, Lu C, Cai L (2017) Cancer cell membrane biomimetic oxygen Nanocarrier for breaking hypoxia induced Chemoresistance. Adv Funct Mater 27(38).  https://doi.org/10.1002/adfm.201703197 CrossRefGoogle Scholar
  46. Treffers LW, Hiemstra IH, Kuijpers TW, Berg TK, Matlung HL (2016) Neutrophils in cancer. Immunol Rev 273(1):312–328.  https://doi.org/10.1111/imr.12444 CrossRefPubMedPubMedCentralGoogle Scholar
  47. Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, Zhou J, Kim HW, Gao W, Lu W, Zhang L (2016) Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials 111:116–123.  https://doi.org/10.1016/j.biomaterials.2016.10.003 CrossRefPubMedPubMedCentralGoogle Scholar
  48. Xuan M, Shao J, Dai L, Li J, He Q (2016) Macrophage cell membrane camouflaged au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces 8(15):9610–9618.  https://doi.org/10.1021/acsami.6b00853 CrossRefPubMedPubMedCentralGoogle Scholar
  49. Zhang L, Li R, Chen H, Wei J, Qian H, Su S, Shao J, Wang L, Qian X, Liu B (2017a) Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. Int J Nanomedicine 12:2129 https://doi.org/10.2147%2FIJN.S126016CrossRefPubMedCentralGoogle Scholar
  50. Zhang Y, Zhang J, Chen W, Angsantikul P, Spiekermann KA, Fang RH, Gao W, Zhang L (2017b) Erythrocyte membrane coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Control Release 263:185.  https://doi.org/10.1016/j.jconrel.2017.01.016 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Zhu JY, Zheng DW, Zhang MK, Yu WY, Qiu WX, Hu JJ, Feng J, Zhang XZ (2016) Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett 16(9):5895–5901.  https://doi.org/10.1021/acs.nanolett.6b02786 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of Biomedical Sciences, BK21 PLUS Centre for Creative Biomedical ScientistsChonnam National University, Chonnam National University Medical SchoolGwangjuSouth Korea
  2. 2.Department of Polymer Science and EngineeringChungnam National UniversityDaejeonSouth Korea

Personalised recommendations